Retinoids are chromophores involved in vision, transcriptional regulation, and cellular differentiation. Members of the short-chain alcohol dehydrogenase/reductase (SDR) superfamily catalyze the transformation of retinol to retinal. Here, we describe the identification and properties of three enzymes from a novel subfamily of four RDHs (RDH11-14) that display dual-substrate specificity, uniquely metabolizing all-trans-and cis-retinols with C 15 pro-R specificity. RDH11-14 could be involved in the first step of all-trans-and 9-cis-retinoic acid production in many tissues. RDH11-14 fill the gap in our understanding of 11-cis-retinal and all-trans-retinal transformations in photoreceptor (RDH12) and retinal pigment epithelial cells (RDH11). The dual-substrate specificity of RDH11-14 explains the minor phenotype associated with mutations in 11-cis-retinol dehydrogenase (RDH5) causing Fundus Albipunctatus in humans and engineered mice lacking RDH5. Furthermore, photoreceptor RDH12 could be involved in the production of 11-cis-retinal from 11-cis-retinol during regeneration of the cone visual pigments. These newly identified enzymes add new elements to important retinoid metabolic pathways that have not been explained by previous genetic and biochemical studies.
INTRODUCTION
Retinoids are indispensable light-sensitive elements of vision and also serve as essential modulators of cellular differentiation and proliferation in diverse cell types, including those comprising the epithelium and immune system. Retinoids modulate the growth of both normal and malignant cells through their binding to retinoid receptors. All-trans-retinoic acid signals through specific interactions with the nuclear retinoic acid receptors (RARs), while it's isomer, 9-cis-retinoic acid, is a high-affinity ligand of RARs and retinoid X receptors (RXRs). In the retina, light-dependent photoisomerization of 11-cis-retinylidene to the all-trans-retinylidene moiety of rod and cone photoreceptors is a key reaction that triggers visual sensation (1) . Restoration of the visual chromophore occurs through a complex set of reactions, termed the retinoid cycle, in photoreceptor cells and adjacent retinal pigment epithelial cells (RPE) (2) . Dietary deficiencies in retinoids and retinoid precursors cause visual impairment, developmental abnormalities, and immune deficiency (3, 4) .
Transformations of retinoids occur mostly through enzymatic or photochemical reactions, although they readily isomerize non-enzymatically to thermodynamic equilibrium when unprotected by the retinoidbinding proteins (5) . The key enzymes involved in retinoid metabolisms are alcohol and aldehyde dehydrogenases that convert retinols to aldehydes and aldehydes to carboxylic acids, respectively. The first oxidation reaction is catalyzed by a large number of enzymes from the SDR superfamily (6, 7) and by classic medium-chain alcohol dehydrogenases (8) . SDRs are weakly conserved in their primary sequences, with the exception of key residues involved in catalysis, nucleotide recognition, and members of closely-related subfamilies. SDRs also display NADP or NAD cofactor preference and, if they are retinol dehydrogenases (RDHs), favor all-trans-or cis-retinol substrates. Some RDH enzymes also catalyze the oxidation of steroids in addition to retinols (9) . The large numbers of SDRs expressing RDH activity suggest a low specificity for retinol recognition of the substrate-binding site. Localized expression or high levels of these enzymes in the photoreceptor and RPE cells, where heavy traffic of diffusible retinoids occurs, strongly suggest that retinols are their in vivo substrates. The role of specific SDRs in vision has been determined from the biochemical characterization of enzymes isolated from specific compartments of the retina, analyses of retinoid flow in genetically engineered mice, and from associations of human visual dysfunctions with specific disabling mutations in one of the SDR genes, RDH5 (reviewed in (2) ).
The present study was undertaken to resolve the discrepancy between biochemical and genetic analyses of the RDH activity responsible for 11-cis-retinal and 9-cis-retinal production. An enzyme encoded by the RDH5 gene (10,11), 11-cis-RDH, was proposed to be responsible for both 11-cis-retinal and 9-cisretinal production due to its relaxed substrate specificity (12) (13) (14) (15) . However, the disruption of this gene in a mouse model led to uninterrupted production of 11-cis-retinal (16, 17) and a lack of any embryonic abnormalities. Furthermore, patients with Fundus Albipunctatus who also have a disabling mutation in the RDH5 gene still show efficient production of the chromophore, albeit with slower kinetics (18, 19) . Here, we characterized members of a novel subfamily of SDRs cloned from the retina that display novel properties of dual cis-and all-trans-retinol substrate specificities. The recognition of both types of isomers studied by stereospecific substrates unravels a novel mode of substrate recognition. The RDH11 transcript has been previously identified as one that exhibits increased expression on exposure to androgens in the LNCaP prostate cancer cell line (20) and is proposed to be involved in the metabolism of retinoids (21) .
MATERIALS AND METHODS
Cloning of human RDH11-14. Full-length RDHs were amplified by PCR from human (RDH11- 13) or mouse (RDH14) retina cDNA libraries using primers FH497 (5' GAGATGGTTGAGCTCATGTTC3') and FH498 (5'GTTAGTCTATTGGGAGGCC3') for RDH11, FH500
(5'ACGATGCTGGTCACCTTGGGACTG3') and FH501 (5'ACGATGCTGGTCACCTTGGGACTG3') for RDH12, FH502 (5'ATGAGCCGCTACCTGCTGCCG3') and FH503 (5'TTATCTGGGGAGGGGCTGCTC3'') for RDH13, and FH490 (5'GTTATGGCAGTGGCTAGTGTGG3') and FH491 (5'CTATTTTAGAATGCCAACCATCACTT3') for RDH14. The reactions were cycled through 35 cycles of 94°C for 30 s, 68°C for 2.5 min, followed by 7 min at 68°C. The PCR products were cloned in the pCRII-TOPO vector (Invitrogen) and sequenced by dideoxyterminator sequencing (ABI-Prism, Perkin-Elmer).
Expression of RDH12-14 in Escherichia coli.
The coding sequences for RDH12 and RDH14 were cloned as a fragment into BamHI-XhoI or EcoRI-XbaI sites in pMAL-c2X(New England Biolabs). This joins RDH12 and RDH14 in fusion with the maltose-binding protein. RDH12 and RDH14 were expressed in TOP10 bacteria after induction with 0.5 mM IPTG and purified on an amylose column following the manufacturer's protocol. The coding sequence for RDH13 was cloned into EcoRI-digested pET30A. This fusion construct joins RDH13 to a 6 His tag. RDH13 was expressed in BL21 bacteria after induction with 0.2 mM IPTG and purified on a Ni 2+ -NTA column in denaturing conditions according to the manufacturer's protocol (Qiagen).
Expression of RDH11, RDH12
, and RDH14 in insect and ARPE19 cells. The coding sequence of human RDH11, human RDH12, human RDH13, or mouse RDH14 was transferred as a NotI-KpnI fragment in NotI-KpnI-digested pFASTBac. Recombinant RDH baculoviruses were then obtained by transposition in DH10BAC bacteria and amplified after transfection in SF9 cells. The expression of recombinant proteins was tested three days after transfection and the cells were collected for enzymatic assays. ARPE19 cells were transfected with baculoviruses and expression was driven by the CMV promoter as described previously (22) .
Immunocytochemistry and in situ hybridization. The in situ hybridization techniques and preparation of the mouse, bovine, and monkey retinal sections were carried out as described previously (23) . cDNA fragments of mouse and human RDH12 were cloned into PCRII-TOPO vectors and linearized with appropriate endonucleases. Antisense and sense RNA probes (0.9-1 kb) were synthesized by run-off transcription from the SP6 or T7 promoter with digoxigenin-UTP, as recommended in the manufacturer's protocol (Roche Molecular Biochemicals).
For immunohistochemistry,, retinal sections were blocked for non-specific labeling by incubating in 1.5% normal goat serum in PBST buffer (136 mM NaCl, 11.4 mM sodium phosphate, 0.1% Triton X-100, pH 7.4) for 15 min at room temperature. Sections were incubated with purified anti-RDH11 mAb overnight at 4˚C. Controls were prepared by absorbing the anti-RDH11 mAb with an excess amount of RDH11 peptide (0.5 µg/ml). Sections were rinsed in PBST and incubated with indocarbocyanine (Cy3)-conjugated goat anti-mouse IgG. Sections were then rinsed in PBST and mounted in 50 µl 2% 1,4-diazabicyclo-2,2,2-octane in 90% glycerol to slow photobleaching. Sections were analyzed under a confocal microscope (Zeiss LSM510). Bright field images were captured with Nomarski optics (NIKON).
Preparation of anti-RDH11,RDH13,RDH14 and RDH5.The antibody against RDH11 was generated against CHVAWVSVQARNETIAR-CONH 2 peptide (21). Bacterially expressed and purified RDH13 and RDH14 was used to immunize a BALB/c mouse to obtain an anti-RDH13/14 antiserum. Mouse anti-RDH5 monoclonal antibodies were raised against RDH5-His 6 purified from RDH5-His 6 infected Sf9 cells (24) .
Retinoids. All reactions involving retinoids were carried out under dim-red light conditions.
Retinoids were stored in DMF under argon at -80 o C. Rtinoids were purified by normal phase HPLC (Beckman, Ultrasphere-Si, 4.6 mm x 250 mm) with 10% ethyl acetate/90% hexane at a flow rate of 1.4 ml/min using an HP1100 with an online diode-array detector and HP Chemstation A.06.03 software.
extracted with 500 µl of hexane. Radioactivity was measured in the organic phase by scintillation counting.
RESULTS
Initial screening of prostate short-chain dehydrogenase/reductase I (PSDR1) expression, an enzyme cloned by the Nelson group (20) from prostate epithelium, reveals that this enzyme is also expressed in the eye (data not shown). Therefore, the name PSDR1 was changed into RDH11 to reflect its broader expression.
RDH11-14 sequence analyses and gene structures
Nucleic acid and protein sequence databases were searched with the RDH11 cDNA sequence (identical to the sequence of the PSDR1 gene product (20) share ~60% similarity amongst themselves ( Figure 1A and 1B).
These proteins contain two motifs highly conserved among SDRs: the cofactor-binding site (GXXXGXG) and catalytic residues (YXXXK). SDRs contain a motif at the amino-terminus consisting of β-strand A, α-helix B, β-strand B, and α-helix C (part of the βA-αB-βB-αC-βC-αD-βD that forms the Rossman fold), which interact with the adenosine monophosphate moiety of the cofactor. The residues present at the junctions βA-αB and βB-αC are thought to be important in selectivity for NAD(H) versus NADP(H). For favorable interaction with NADP(H), positively charged residues are present at the βA-αB junction (glycine-rich motif) and/or at the beginning of α-helix C (7). For all RDH11-14, no charged amino acids are present in the Gly-rich motif (GANTGIG or GANSGLG for RDH14) and there are positively charged residues present at the βB-αC junction (RDVEK, RDVLK, RDMEK, RDRARA for RDH11, 12, RDH13 and RDH14, respectively), suggesting a preference for NADP/NADPH ( Figure 1A ).
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The tissue distribution of RDH11-14 was deduced from the array of expressed sequencing tags (ESTs) displayed in databases corresponding to these RDHs. RDH11 was reported to be expressed abundantly in prostate tissue, but also in eye, kidney, pancreas, liver, testis, heart, and brain (20) . In addition, ESTs corresponding to RDH11 were also found in libraries from eye, skin, and muscle. ESTs matching RDH12 were identified in multiple tissues, most of them from eye, but also some from kidney, brain, skeletal muscle and stomach. RDH13 ESTs were obtained mostly from eye, pancreas, placenta, and lung.
Many ESTs from brain, kidney, pancreas, and placenta correspond to RDH14. 
RDH activity of RDH11, RDH12 and RDH14
RDH11 catalyzed the reduction of all-trans-retinal and its 9-cis, 11-cis, and 13-cis-retinal isomers.
The activity was observed in the presence of NADPH and with Sf9 insect cell membranes only when Sf9 cells were transfected with the cDNA encoding RDH11 ( Figure 5 ). The products were clearly identified by the characteristic spectrum for each retinol isomer and a retention time that was similar to authentic standards ( Figure 5 ). This analysis avoids problems associated with the isomerization among retinols during incubation or sample handling. The activity toward 13-cis-was the lowest of the retinoid substrates tested and was only detected using high-sensitivity HPLC analysis. The summary of the product conversion is illustrated in Figure 6A . RDH12 and RDH14 have very similar properties to those of RDH11 ( Figure 6B and 6C). However, RDH13, expressed in insect cells (Figure 4 ), displayed no RDH activity. The double specificity exhibited by RDH11, RDH12, and RDH14 toward cis-and all-trans-retinoids makes these enzymes unique among short-chain RDHs.
RDH11, RDH12 and RDH14 demonstrate a clear specificity for the pro-S hydrogen on C4 of NADPH (shown only for one enzyme, Fig. 6D ) and the pro-R hydrogen on C 15 of all highly active retinols (Fig. 6E ). These properties resemble those of the photoreceptor dehydrogenase, prRDH (24, 31) , and not those of the RPE enzyme RDH5 (16, 24) , which is active toward the pro-S position of both substrates. The results also suggest that these enzymes catalyze the reaction in both directions: NADPH/retinals ↔ NADP/retinols. RDH11, RDH12 and RDH14 showed equal utilization of 11-cis-retinal and all-trans-retinal when these substrates are present at equal concentrations in the same mixture (data not shown), a property that suggests similar efficiency toward both substrates. No steroid dehydrogenase activity was detected for RDH11, RDH12 and RDH14. The activity of the RDH11-14, photoreceptor prRDH and RDH5, were potently inhibited by retinoic acids (for example, 9-cis-retinoic acid, K I ~1 µM for RDH11), recombinant CRBP1 (Table 1 , supplement, prRDH) and CRALBP ( Table 2 , supplement, RDH5).
Co-purification of RDH5 and RDH11 and expression of RDHs in immortal ARPE19 cells
When RDH5 was purified from RPE membranes using anti-RDH5 monoclonal affinity chromatography, NAD(H)-(RDH5) and NADP(H)-dependent (RDH11) enzymes were also isolated based on immunoblotting and retinol activity profiles ( Figure 7A ). The activity was suppressed by diluting [4-RDH11 ( Figure 5 ), or the sum of stereopreferences of RDH5 ( Figure 7B ) and the remaining activity in RPE membranes derived from RDH5-/-mice ( Figure 7C ). This suggests that the enzyme responsible for oxidation of 11-cis-retinol in these membranes is RDH11.
As with many enzymes involved in retinoid metabolism, the expression of RDH11 and RDH5 are lost in ARPE19, an immortalized RPE cell line (Figure 2A, supplement) , although other functions of retinal epithelium are preserved. These cells also lack RDH activity toward retinals ( Figure 2B , supplement). These findings are not due to a secondary effect caused by a lack of other retinoid processing enzymes because transfecting these cells with the RDH11 or 12 cDNAs restores RDH activity. This observation supports the hypothesis that RDH11 is involved in 11-cis-retinol oxidation in the RPE ( Figure 2C , supplement). 
Retinoid flow in the eye
RDH11 localizes in RPE, where it likely plays a key role in producing the aldehyde forms of alltrans-and 11-cis-isomers ( Figure 8 ). All-trans-retinal is utilized by RGR (retinal G-protein-coupled receptor), a hypothetical photoisomerase that is essential for replenishing 11-cis-retinals at high illumination levels (38) . It has been proposed that RDH5 forms a complex with this RGR (39) . Here, we showed that RDH11 may interact with RDH5 ( Figure 7A ), forming possible homo-and heterodimeric or oligomeric complexes (7).
Another function of RDH11, along RDH5, might be to produce 11-cis-retinal from 11-cis-retinol.
RDH5 is responsible for the majority of RDH activity in RPE membranes. In humans, mutations in this gene are associated with Fundus Albipunctatus, a disease expressed by delayed dark adaptation of both cones and rods. Detailed analyses of RDH5-/-mice have identified only a minor phenotype manifested by the accumulation of 13-cis-retinoids. These studies indicate that another enzyme is responsible for the production of 11-cis-retinal under bleaching conditions (16) . The RDH(s) responsible for the production of 11-cis-retinal in RPE membrane from RDH5-/-mice display pro-S hydrogen specificity for NADPH and utilize 9-cis-and 11-cis-retinal, but not 13-cis-retinal (16) . Furthermore, pro-R stereospecificity toward 11-cis-retinol with NADP was observed in bovine RPE (24) . The pro-R stereospecificity toward the retinols is a rare property among SDRs. These results are in perfect agreement with the properties of RDH11 determined in the experiments reported here ( Figure 5, 6 and 7) . Therefore, it is highly probable that RDH11 is the missing enzyme of the RPE in vertebrates as no other known RDH exhibits similar properties (Table 3 , supplement).
RDH12 is expressed in photoreceptors cells while RDH14 appears to be a minor enzymatic component of ocular retinoid metabolism based upon its level of expression. The substrate specificity of RDH12 indicates that it functions in a fashion complementary to previously identified RDHs (31, 32) involved in the production of all-trans-retinol from all-trans-retinal. We hypothesize that RDH12 might be the key enzyme in the formation of 11-cis-retinal from 11-cis-retinol during regeneration of the cone visual pigments (reviewed in (2)).
Bliss reported that the equilibrium constant for reduction of all-trans-retinal is 10 -2 to 10 between pH 6.6 to 9.4, respectively (40). Depending on the layer of the retina, the ratio of NADP to NADPH is between 4 to 1 and 1.5 to 1, while NAD to NADH could be as high as 300 to 1 (41) . Therefore, reaction catalyzed by NAD-dependent enzymes will be mostly oxidizing RDHs, while NADP-dependent enzymes will have ability to catalyzed reactions in both directions, depending on the retinol/retinal ratio.
Involvement of RDH11-14 in retinoid transformation and all-trans-and 9-cis-retinoic acid production
The RDH5 gene product has been implicated in the production of 9-cis-retinal before this aldehyde is further oxidized to 9-cis-retinoic acids (12, 14) . However, disabling mutations in men and mice produce no embryonic developmental abnormalities (16) (17) (18) (19) . In this report, we provide unequivocal evidence that RDH11-14 display high activity toward 9-cis-and all-trans-retinol. The unique substrate utilization of alltrans-and cis-retinoids, combined with the specific expression of these enzymes, identifies a novel pathway involving the cooperative production of both retinoic acids by the same enzyme that may activate combinations of the RAR and RXR nuclear receptors (4). In addition, RDH11-14 may participate in the reduction of all-trans-retinal and 9-cis-retinal as they are formed in reactions catalyzed by dioxygenases from dietary 9-cis-β-carotene (42) . These retinols are stored in the form of retinyl esters before use. Because 9-cis-retinal is more stable than 9-cis-retinol, an alternative pathway in the production of 9-cis-isomers is the isomerization of all-trans-retinol to 9-cis-retinol (43) . Although the equilibrium is shifted toward the alltrans-isomers (5), small amounts of 9-cis-retinal would be trapped as it is formed and further oxidized by aldehyde dehydrogenases (44). These RDH properties do not eliminate the possibility that these dehydrogenases may also be involved in redox reactions of other unidentified lipophilic substrates, as has been documented for other SDRs that are fairly unrestricted in substrate recognition (9) . SDRs are a redundant group of enzymes regulated by the availability of hydrophobic substrates and the redox potential (24)). Table 1 , supplement. Effect of CRBP1 on ROS (prRDH) and RDH11-14. The assays were carried out as described above for the reduction and oxidation of retinoids, except 50 mM MES buffer, pH 6.1, was used for the reduction assay. After mixing CRBP1 and retinoids at ~1:1 ratio (~20-30 µM), the assays were pre-incubated at 37 o C for 10 min before adding RDH11, RDH12 and RDH14, or ROS membranes to initiate the reaction. Table 2 , supplement. Effect of CRALBP on RDH5 and RDH11-14. The assays were carried out as described above for the reduction and oxidation of retinoids, except MES buffer at pH 6.1 was used for the reduction assay. After mixing CRALBP and retinoids at ~1:1 ratio (~20-30 µM), the assays were pre-incubated at 37 o C for 10 min before adding RDH11, RDH12, and RDH14, or RDH5 to initiate the reaction. 
